Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARLSMED, INC.CARL · Entity 5551 | Chief Commercial Officer | January 28, 2026 | January 30, 2026 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | Chief Commercial Officer | May 07, 2023 | May 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARLSMED, INC.
Report date January 28, 2026 · Filed January 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,977 |
Reported balance
After 2026-01-28 transaction · row 1
1 source rowRow 1 · 2026-01-28 · Grant · Acquired 44,977 · Balance 44,977 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date.
SURGALIGN HOLDINGS, INC.
Report date May 07, 2023 · Filed May 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,012 |
Reported balance
After 2023-05-07 transaction · row 1
1 source rowRow 1 · 2023-05-07 · Tax withholding · Disposed 178 · Balance 64,012 F1: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2026 Filed Jan 30, 2026 17:24 UTC | CARLSMED, INC. CARL · Entity 5551 | GrantCommon Stock | 44,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-032076 · ownership.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,977 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 20:34 UTC | CARLSMED, INC. CARL · Entity 5551 | GrantStock Options (Right to Buy) · Derivative | 71,429 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-25-098545 · ownership.xml · derivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,008 Underlying: Common Stock · 71,429 shares Expires 2035-07-09 F1 · derivative.exercise_date: The unvested stock options are convertible into approximately 71,429 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date. Read SEC document |
| May 07, 2023 Filed May 8, 2023 14:13 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 178 | $1.20 | $213.60 |
DisclosureSEC source: 0001209191-23-027891 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,012 F1 · shares: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 09:59 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 145 | $1.60 | $232.00 |
DisclosureSEC source: 0001209191-23-022496 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,190 F1 · shares: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 09:54 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 178 | $2.14 | $380.92 |
DisclosureSEC source: 0001209191-23-007959 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,335 F1 · shares: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 17:37 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 34,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046415 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,513 F1 · shares: The Restricted Stock Units will vest over two years with one-half of the total number of shares vesting on the first anniversary of the award date and the remaining shares vesting prorated quarterly. F2 · balance_after: Total shares includes 1,056 shares purchased under the Company's Employee Stock Purchase Plan on June 30, 2022, which is exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 10:28 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 127 | $3.41 | $433.07 |
DisclosureSEC source: 0001209191-22-040018 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,041 F1 · balance_after: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 11:36 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | Tax withholdingCommon Stock | 3,676 | $0.30 | $1,118.61 |
DisclosureSEC source: 0001209191-22-021890 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875,102 F1 · shares: Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 11:44 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | PurchaseWarrant (right to buy) · Derivative | 163,043 | $0.00 Strike: $0.60 | $16.30 |
DisclosureSEC source: 0001209191-22-010123 · doc4.xml · derivative · entry 2 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,462 Underlying: Common Stock · 163,043 shares Expires 2027-02-15 Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 11:44 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | PurchaseCommon Stock | 217,391 | $0.46 | $99,956.38 |
DisclosureSEC source: 0001209191-22-010123 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 878,778 F1 · balance_after: Total shares includes 17,985 shares purchased under the Company's Employee Stock Purchase Plan on December 31, 2021, which is exempt under Rule 16b-3(c). Read SEC document |
| May 07, 2021 Filed May 10, 2021 16:33 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 25,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031244 · doc4.xml · nonDerivative · entry 2 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,402 F2 · shares: Represents a portion of the 2020 short-term incentive plan; vests on May 7, 2022. Read SEC document |
| May 07, 2021 Filed May 10, 2021 16:33 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 156,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031244 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,550 F1 · shares: The Restricted Stock Units will vest over three years with 1/3 of the shares vesting after year one and remaining 2/3 of the shares vesting prorated quarterly. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 10:26 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | PurchaseCommon Stock | 333,333 | $1.50 | $499,999.50 |
DisclosureSEC source: 0001209191-21-006627 · doc4.xml · nonDerivative · entry 1 Durall William Scott · CIK 0001818744 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,884 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.